Cargando…

A Clinical Prediction Rule for Protease Inhibitor Resistance in Patients Failing Second-Line Antiretroviral Therapy

BACKGROUND: Most adults with virological failure on second-line antiretroviral therapy (ART) in resource-limited settings have no major protease inhibitor (PI) resistance mutations. Therefore, empiric switches to third-line ART would waste resources. Genotypic antiretroviral resistance testing (GART...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cohe, Karen, Stewart, Annemie, Kengne, Andre P., Leisegang, Rory, Coetsee, Marla, Maharaj, Shavani, Dunn, Liezl, Hislop, Michael, van Zyl, Gert, Meintjes, Graeme, Maartens, Gary
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6802273/ https://www.ncbi.nlm.nih.gov/pubmed/30531296 http://dx.doi.org/10.1097/QAI.0000000000001923

Ejemplares similares

Third-line antiretroviral therapy in Africa: effectiveness in a Southern African retrospective cohort study
por: Meintjes, Graeme, et al.
Publicado: (2015)

Case report: Emergence of dolutegravir resistance in a patient on second-line antiretroviral therapy
por: Mahomed, Kairoonisha, et al.
Publicado: (2020)

Improving the evidence base of Markov models used to estimate the costs of scaling up antiretroviral programmes in resource-limited settings
por: Leisegang, Rory, et al.
Publicado: (2010)

Short term adherence tool predicts failure on second line protease inhibitor-based antiretroviral therapy: an observational cohort study
por: Court, Richard, et al.
Publicado: (2014)

A Novel Markov Model Projecting Costs and Outcomes of Providing Antiretroviral Therapy to Public Patients in Private Practices versus Public Clinics in South Africa
por: Leisegang, Rory, et al.
Publicado: (2013)

Early and Late Direct Costs in a Southern African Antiretroviral Treatment Programme: A Retrospective Cohort Analysis
por: Leisegang, Rory, et al.
Publicado: (2009)

Risk Factors for Incident Diabetes in a Cohort Taking First-Line Nonnucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy
por: Karamchand, Sumanth, et al.
Publicado: (2016)

Initial Supplementary Dose of Dolutegravir in Second-Line Antiretroviral Therapy: A Noncomparative, Double-Blind, Randomized Placebo-Controlled Trial
por: Zhao, Ying, et al.
Publicado: (2023)

Factors Influencing Retention in Care after Starting Antiretroviral Therapy in a Rural South African Programme
por: Boyles, Tom H., et al.
Publicado: (2011)

Virologic efficacy of tenofovir, lamivudine and dolutegravir as second-line antiretroviral therapy in adults failing a tenofovir-based first-line regimen: a prospective cohort study
por: Keene, Claire M, et al.
Publicado: (2021)

Recycling tenofovir in second-line antiretroviral treatment with dolutegravir: outcomes and viral load trajectories to 72 weeks
por: Keene, Claire M, et al.
Publicado: (2023)

A multi-parameter diagnostic clinical decision tree for the rapid diagnosis of tuberculosis in HIV-positive patients presenting to an emergency centre
por: van Hoving, Daniël Jacobus, et al.
Publicado: (2022)

Development of a clinical prediction rule to diagnose Pneumocystis jirovecii pneumonia in the World Health Organization’s algorithm for seriously ill HIV-infected patients
por: Maartens, Gary, et al.
Publicado: (2018)

Early severe morbidity and resource utilization in South African adults on antiretroviral therapy
por: de Cherif, Teresa K Smith, et al.
Publicado: (2009)

Risk of immune reconstitution inflammatory syndrome with integrase inhibitors versus other classes of antiretrovirals: a systematic review and meta-analysis of randomised trials
por: Zhao, Ying, et al.
Publicado: (2022)

Complications of Antiretroviral Therapy Initiation in Hospitalised Patients with HIV-Associated Tuberculosis
por: van der Plas, Helen, et al.
Publicado: (2013)

Southern African HIV Clinicians Society adult antiretroviral therapy guidelines: Update on when to initiate antiretroviral therapy
por: Meintjes, Graeme, et al.
Publicado: (2015)

Adult antiretroviral therapy guidelines 2017
por: Meintjes, Graeme, et al.
Publicado: (2017)

Dolutegravir for second-line treatment: Programmatic implications of new evidence
por: Zhao, Ying, et al.
Publicado: (2022)

Standard versus double dose dolutegravir in patients with HIV-associated tuberculosis: a phase 2 non-comparative randomised controlled (RADIANT-TB) trial
por: Griesel, Rulan, et al.
Publicado: (2021)

The Persistent Challenge of Advanced HIV Disease and AIDS in the Era of Antiretroviral Therapy
por: Calmy, Alexandra, et al.
Publicado: (2018)

Comparison of six methods to estimate adherence in an ART-naïve cohort in a resource-poor setting: which best predicts virological and resistance outcomes?
por: Orrell, Catherine, et al.
Publicado: (2017)

Accumulation of Protease Mutations among Patients Failing Second-Line Antiretroviral Therapy and Response to Salvage Therapy in Nigeria
por: Rawizza, Holly E., et al.
Publicado: (2013)

Southern African HIV Clinicians Society Guidance on the use of dolutegravir in first-line antiretroviral therapy
por: Moorhouse, Michelle A., et al.
Publicado: (2018)

Ten simple rules for failing successfully in academia
por: Gaillard, Stefan, et al.
Publicado: (2022)

Patient and provider delay in tuberculosis suspects from communities with a high HIV prevalence in South Africa: A cross-sectional study
por: Meintjes, Graeme, et al.
Publicado: (2008)

Clofazimine for the treatment of tuberculosis
por: Stadler, Jacob A. M., et al.
Publicado: (2023)

Pharmacy Refill Adherence Compared with CD4 Count Changes for Monitoring HIV-Infected Adults on Antiretroviral Therapy
por: Bisson, Gregory P, et al.
Publicado: (2008)

Cases of antiretroviral-associated gynaecomastia reported to the National HIV & Tuberculosis Health Care Worker Hotline in South Africa
por: Njuguna, Christine, et al.
Publicado: (2016)

AntiRetroviral Therapy In Second-line: investigating Tenofovir-lamivudine-dolutegravir (ARTIST): protocol for a randomised controlled trial
por: Zhao, Ying, et al.
Publicado: (2021)

Antiretroviral Treatment Outcomes amongst Older Adults in a Large Multicentre Cohort in South Africa
por: Fatti, Geoffrey, et al.
Publicado: (2014)

2023 Southern African HIV Clinicians Society Adult Antiretroviral Therapy Guidelines: What’s new?
por: Nel, Jeremy, et al.
Publicado: (2023)

Clinical prediction rules for failed nonoperative reduction of intussusception
por: Khorana, Jiraporn, et al.
Publicado: (2016)

‘Covering the tail’ after stopping efavirenz-based antiretroviral therapy
por: Maartens, Gary
Publicado: (2020)

Barriers to Initiation of Antiretrovirals during Antituberculosis Therapy in Africa
por: Pepper, Dominique J., et al.
Publicado: (2011)

Systematic Review of Antiretroviral-Associated Lipodystrophy: Lipoatrophy, but Not Central Fat Gain, Is an Antiretroviral Adverse Drug Reaction
por: de Waal, Reneé, et al.
Publicado: (2013)

Rapid emergence of resistance to antiretroviral treatment after undisclosed prior exposure: A case report
por: Rossouw, Theresa M., et al.
Publicado: (2019)

It is time to consider third-line options in antiretroviral-experienced paediatric patients?
por: van Zyl, Gert U, et al.
Publicado: (2011)

Factors Associated with the Development of Drug Resistance Mutations in HIV-1 Infected Children Failing Protease Inhibitor-Based Antiretroviral Therapy in South Africa
por: Rossouw, Theresa M., et al.
Publicado: (2015)

Sexual size dimorphism in anurans fails to obey Rensch’s rule
por: Liao, Wen Bo, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_j1l73dfksa61p6jv6a9ri0imef